Visceral Leishmaniasis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2013-08-28
Clinical Trial Update: SCH708980 With and Without AmBisome for Visceral Leishmaniasis [Phase 1, Phase 2]
The NIAID-sponsored Phase 1/2 trial of SCH708980 for visceral leishmaniasis, with and without AmBisome, has been withdrawn.